235 related articles for article (PubMed ID: 30732971)
1. Does the subtype of breast cancer affect the diagnostic performance of axillary ultrasound for nodal staging in breast cancer patients?
Vane MLG; van Nijnatten TJA; Nelemans PJ; Lobbes MBI; van Roozendaal LM; Kooreman LFS; Keymeulen KBMI; Smidt ML; Schipper RJ
Eur J Surg Oncol; 2019 Apr; 45(4):573-577. PubMed ID: 30732971
[TBL] [Abstract][Full Text] [Related]
2. The influence of breast cancer subtypes on axillary ultrasound accuracy: A retrospective single center analysis of 583 women.
Helfgott R; Mittlböck M; Miesbauer M; Moinfar F; Haim S; Mascherbauer M; Schlagnitweit P; Heck D; Knauer M; Fitzal F
Eur J Surg Oncol; 2019 Apr; 45(4):538-543. PubMed ID: 30366878
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging.
Upadhyaya VS; Lim GH; Chan EYK; Fook-Chong SMC; Leong LCH
Breast J; 2020 Feb; 26(2):162-167. PubMed ID: 31562691
[TBL] [Abstract][Full Text] [Related]
4. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement.
Ugras S; Stempel M; Patil S; Morrow M
Ann Surg Oncol; 2014 Nov; 21(12):3780-6. PubMed ID: 24952028
[TBL] [Abstract][Full Text] [Related]
6. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
[TBL] [Abstract][Full Text] [Related]
7. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Axillary Ultrasound versus Sentinel Lymph Node Biopsy in Patients with Early Breast Cancer.
Rukanskienė D; Veikutis V; Jonaitienė E; Basevičiūtė M; Kunigiškis D; Paukštaitienė R; Čepulienė D; Poškienė L; Boguševičius A
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32183080
[No Abstract] [Full Text] [Related]
9. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
[TBL] [Abstract][Full Text] [Related]
10. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.
Mamtani A; Barrio AV; King TA; Van Zee KJ; Plitas G; Pilewskie M; El-Tamer M; Gemignani ML; Heerdt AS; Sclafani LM; Sacchini V; Cody HS; Patil S; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3467-3474. PubMed ID: 27160528
[TBL] [Abstract][Full Text] [Related]
11. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
[TBL] [Abstract][Full Text] [Related]
13. Association between molecular subtypes and lymph node status in invasive breast cancer.
Si C; Jin Y; Wang H; Zou Q
Int J Clin Exp Pathol; 2014; 7(10):6800-6. PubMed ID: 25400761
[TBL] [Abstract][Full Text] [Related]
14. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do?
Leenders MW; Broeders M; Croese C; Richir MC; Go HL; Langenhorst BL; Meijer S; Schreurs WH
Breast; 2012 Aug; 21(4):578-83. PubMed ID: 22717665
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated With Node-Positive Disease in Estrogen Receptor-Positive Breast Cancer Patients.
Gallagher J; Elleson KM; Englander K; Chintapally N; Sun W; Whiting J; Laronga C; Lee MC
J Surg Res; 2024 Mar; 295():327-331. PubMed ID: 38061237
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer recurrence according to molecular subtype.
Shim HJ; Kim SH; Kang BJ; Choi BG; Kim HS; Cha ES; Song BJ
Asian Pac J Cancer Prev; 2014; 15(14):5539-44. PubMed ID: 25081661
[TBL] [Abstract][Full Text] [Related]
18. Preoperative axillary ultrasound and fine-needle aspiration biopsy in the diagnosis of axillary metastases in patients with breast cancer: predictors of accuracy and future implications.
Cools-Lartigue J; Sinclair A; Trabulsi N; Meguerditchian A; Mesurolle B; Fuhrer R; Meterissian S
Ann Surg Oncol; 2013 Mar; 20(3):819-27. PubMed ID: 22972506
[TBL] [Abstract][Full Text] [Related]
19. Predicting axillary sentinel node status in patients with primary breast cancer.
Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
[TBL] [Abstract][Full Text] [Related]
20. [Breast cancer subtypes based on ER/PR and Her2 expression: comparison of MR imaging features].
Hao L; Yu RS; Cui F; Ren XC; Xu HB; Xu KY
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(11):819-23. PubMed ID: 23859386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]